EMEA-000298-PIP01-08-M05

  • Email
  • Help

Overview

Product details for Pegasys
Invented namePegasys
Active substance

Peginterferon alfa-2a

Decision numberP/0010/2016
PIP numberEMEA-000298-PIP01-08-M05
Pharmaceutical form(s)Solution for injection
Condition(s)/indication(s)

Treatment of chronic hepatitis B

Treatment of chronic hepatitis C

Route(s) of administrationSubcutaneous use
PIP applicant

Roche Registration Ltd
United Kingdom
E-mail: info.paediatrics@roche.com
Tel. +41 616879411

Decision typePM: decision on the application for modification of an agreed PIP

Decision

Related information